Skip to main content

Table 2 Medication at 12 months

From: Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry

Medication

Cohort I (n = 128)

Cohort II (n = 128)

No DMARD

2 (1.6 %)

10 (7.8 %)

csDMARD only

116 (90.6 %)

104 (81.3 %)

bDMARD

5 (3.9 %)

11 (8.6 %)

Lost to follow-up

5 (3.9 %)

3 (2.3 %)

  1. DMARD disease-modifying antirheumatic drug, csDMARD conventional synthetic disease-modifying antirheumatic drug, bDMARD biologic disease-modifying antirheumatic drug
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us